Carl Zeiss Meditec AG announced that its earnings for the first quarter of fiscal year 2025⁄26 were clearly below those of the previous year. Preliminary revenue for the period amounted to €467 million, down from €490 million in the prior year, with preliminary operating profit (EBITA) dropping to €8 million from €35 million. The company stated that its full-year 2025⁄26 guidance will likely not be achieved due to this weaker business performance. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carl Zeiss Meditec AG published the original content used to generate this news brief via EQS News, a service of EQS Group AG (Ref. ID: adhoc_2264262_en), on January 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

Carl Zeiss Meditec warns FY 2025/26 guidance likely will not be achieved